Browsing Category
Pharma Industry News
4750 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Lupin receives US FDA nod for Nagpur injectable facility manufacturing drug-device combinations
Lupin secures US FDA EIR for its Nagpur injectables facility, boosting export potential and complex generics expansion. Read how this impacts global strategy.
Sigachi Industries secures green signal for massive Dahej SEZ project—3,120 MT/month pharma push begins now
Find out how Sigachi Industries is scaling its pharma manufacturing with a new Dahej SEZ facility cleared for construction.
Prescient Therapeutics secures FDA fast track for PTX-100 to advance CTCL treatment strategy
Find out how Prescient Therapeutics’ PTX-100 just gained FDA Fast Track status, accelerating the path to treating relapsed CTCL.
Clarity Pharmaceuticals begins Phase II SECuRE trial with first patient dosed using 67Cu-SAR-bisPSMA and enzalutamide
Clarity Pharmaceuticals starts Phase II of SECuRE trial for prostate cancer, combining 67Cu-SAR-bisPSMA with enzalutamide in first treated patient.
Brain cancer breakthrough? Telix Pharmaceuticals’ TLX101 boosts survival in early study as stock outlook strengthens
Discover how Telix’s TLX101 therapy is showing new promise for brain cancer as investor sentiment rises with key study results and clinical trial expansion.
Can Biocon Biologics lead biosimilar disruption in ophthalmology with Yesafili?
Biocon Biologics secures 2026 U.S. launch for Yesafili, its interchangeable biosimilar to Eylea. Find out how this reshapes eye care access and competition.
Oncolytics Biotech signs $20m share purchase deal with Alumni Capital to advance pelareorep development
Oncolytics Biotech inks $20M share deal with Alumni Capital to support pelareorep trials in breast and pancreatic cancer. Read how the biotech firm is advancing.
Brazil opens doors to OneSource’s GLP-1 drugs as Bengaluru plant gets ANVISA nod
OneSource earns ANVISA GMP nod for Bengaluru plant, unlocking Brazil’s fast-growing market for GLP-1 biologics. Find out how it boosts global CDMO reach.
Aurobindo Pharma wins key FDA approval for blockbuster blood thinner in $8.5bn US market
Aurobindo Pharma gets USFDA final approval for Rivaroxaban 2.5mg and tentative nod for other doses. Find out what this means for its US market strategy.
Zydus wins FDA nod for DMD drug Jaythari—what it means for rare disease treatment and its stock
Find out how Zydus Lifesciences is expanding rare disease care and investor value with USFDA-approved Jaythari tablets for Duchenne muscular dystrophy.